J4 ›› 2016, Vol. 15 ›› Issue (2): 45-47.
Previous Articles Next Articles
Received:
Online:
Published:
Abstract:
Objective: To compare and evaluate the significance of monitoring maintained hemodialysis(MHD)patient's serum intact parathyroid hormone through the detection of MHD patient's serum intact parathyroid hormone(iPTH)and the concentration of biological activity intact parathyroid hormone l-84(PTH 1-84). Methods: 32 MHD patients from Affiliated Hospital of Dali University were enrolled in this study, the control group included 30 healthy people. The concentrations of serum iPTH and PTH(1-84)were detected by Cobas e2010 automatic chemiluminescence analyzer. And all data was analyzed by SPSS13.0 software for statistical analysis. Results: The serum levels of iPTH and PTH(1-84)were higher in the maintained hemodialysis group than in the control group, difference was statistically significant(P<0.01), the iPTH of the dialysis group was higher than that of PTH(1-84), and the difference was statistically significant(P<0.05), in MHD patients,the serum iPTH and PTH(1-84)showed a significant correlation respectively(r=0.927 7,P<0.01), there was no significant difference between normal control group iPTH and PTH(1-84)(P>0.05).Conclusion: In MHD patients, the concentrations of serum iPTH and 1-84(PTH)were significantly higher and there was a positive correlation between them, so the value of PTH(1-84)diagnosis of renal osteodystrophy is better than iPTH.
Key words: maintenance hemodialysis, intact parathyroid hormone(iPTH), biological activity intact parathyroid hormone l-84
CLC Number:
R459.5
Liu Jin, Xiao Yuhui, Han Hong, Deng Tianli, Tang Xuhui. Clinical Study of Serum iPTH and PTH(1-84)in Maintained Hemodialysis Patients[J]. J4, 2016, 15(2): 45-47.
0 / / Recommend
Add to citation manager EndNote|Ris|BibTeX
URL: http://journal15.magtechjournal.com/Jwk_dlxyzk/EN/
http://journal15.magtechjournal.com/Jwk_dlxyzk/EN/Y2016/V15/I2/45
〔1〕徐可为,刘徽婷. 肾衰竭患者血清甲状旁腺激素检测的 临床应用〔J〕.医学综述,2011,7(17):2163-2164. 〔2〕贾艳丽,刘惠兰. 甲状旁腺素及骨转运指标的测定在维 持性血液透析患者肾性骨病诊断中的意义〔J〕. 首都医 科大学学报,2010,31(6):803-807. 〔3〕赵文娟,杨乃龙.内分泌和代谢病功能检查〔M〕.北京:人 民卫生出版杜,2013:184-209. 〔4〕李春红,田洁. 影响维持性血液透析患者甲状旁腺素水 平的相关因素分析〔J〕. 天津医药,2010,38(3):234-235. 〔5〕GABRIELLA B,HENRIETT B. Switching between para? thormone(PTH)assays:the impact on the diagnosis of re? nal osteodystrophy〔J〕. Clin Chem Lab Med,2012,485:1-6. 〔6〕KAREN T,LIZHEN O,SUNIL K,et al. Comparison of the Elecsys PTH(1- 84) assay with four contemporary second generation intact PTH assays and association with other biomarkers in chronic kidney disease patients〔J〕. Clinical Biochemistry,2013,46:781-786. 〔7〕刘东,高卓,魏学明. 甲状旁腺激素水平对维持性血液透 析患者生存质量的影响〔J〕. 山西医科大学学报,2014, 45(5):385-388. 〔8〕BROSSARD J H,LEPAGE R,CARDINAL H,et al. Influ? ence of glornerular filtration rate on non-(1-84)parathy? roid hormone(PTH) detected by intact assays〔J〕. Clin Chem,2000,46:697-703. 〔9〕姚勇,魏天静,何洁. 免疫放射分析与电化学发光法测 定全段甲状旁腺激素的比较〔J〕. 放射免疫学杂志 2012,25(6):634-635. 〔10〕成世立,杨杰凤. 血液透析滤过对维持性透析患者甲状 旁腺激素清除的效果观察〔J〕. 白求恩医学杂志,2015, 13(1):73-74.